Skip to main content

NanoInk Taps Cambridge Bioscience as UK, Ireland Distributor


Cambridge Bioscience will be NanoInk's exclusive distributor in the UK and Ireland, NanoInk said this week.

Cambridge Bioscience will distribute NanoInk’s nanofabrication instruments, including its NLP2000 System and the DPN 5000 System, both of which can support nanoarray-based protein analysis, nanoengineering, and biomaterial research.

Robert Marchmont, general manager of NanoInk's nanofabrication systems division, in a statement said that Cambridge Bioscience has "strong relationships" within NanoInk's target customer base in the UK and Ireland. "Its sales and marketing team has the background required to understand the scientific market and they have proven expertise in selling technically sophisticated equipment into that space," he said.

Skokie, Ill.-based NanoInk has announced a host of distribution pacts in recent months. In September, it appointed NanoGulf as its distributor in parts of the Middle East and inked agreements with SciTech and Gaia Science as its distributors in the Asia-Pacific region (BAN 9/6/2011).

The Scan

WHO OKs Emergency Use of Sinopharm Vaccine

The World Health Organization has granted emergency approval for Sinopharm's SARS-CoV-2 vaccine, the Guardian reports.

Scientific Integrity Panel to Meet

According to the Associated Press, a new US scientific integrity panel is to meet later this week.

Trying in the Eye

NPR reports that a study of Editas Medicine's CRISPR therapy for Leber congenital amaurosis has begun.

PLOS Papers on Cerebellum Epigenetics, Copy Number Signature Tool, Acute Lung Injury Networks

In PLOS this week: epigenetics analysis of brain tissue, bioinformatics tool to find copy number signatures in cancer, and more.